Casdin Capital, LLC Diversified Active

Location: New York, NY

CIK: 0001534261 · Show all filings

Period: Q4 2019 (← Previous) (Next →)

Filing Date: Feb 14, 2020

Total Value: $1.087B (100.0% shares, 0.0% debt)

Holdings (32)

SRPT SAREPTA THERAPEUTICS INC 8.0%
Value $86.46M Shares 670,000 Est. Cost $121.78 Unrealized -17.1%
BLUEBIRD BIO INC 7.8%
Value $85.12M Shares 970,000 Est. Cost $24764.35 Unrealized
CDXS CODEXIS INC 7.5%
Value $81.13M Shares 5,073,780 Est. Cost $13.94 Unrealized +6.1%
BLUEPRINT MEDICINES CORP 6.9%
Value $75.3M Shares 940,000 Est. Cost $9221.69 Unrealized
MYOKARDIA INC 6.7%
Value $73.25M Shares 1,005,000 Est. Cost $39.07 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 5.5%
Value $59.31M Shares 515,000 Est. Cost $81.37 Unrealized +22.5%
INVITAE CORP 5.4%
Value $58.69M Shares 3,638,388 Est. Cost $10040.39 Unrealized
CONSTELLATION PHARMCETICLS I 5.3%
Value $57.13M Shares 1,212,734 Est. Cost $6.31 Unrealized
AUDENTES THERAPEUTICS INC 4.7%
Value $51.46M Shares 860,000 Est. Cost $26.14 Unrealized
FATE FATE THERAPEUTICS INC 4.6%
Value $49.9M Shares 2,550,000 Est. Cost $4.33 Unrealized +266.9%
MAGENTA THERAPEUTICS INC 4.3%
Value $46.97M Shares 3,098,121 Est. Cost $1872.70 Unrealized
BLFS BIOLIFE SOLUTIONS INC 3.7%
Value $39.94M Shares 2,468,571 Est. Cost $15.40 Unrealized +5.6%
AGIO AGIOS PHARMACEUTICALS INC 3.6%
Value $39.39M Shares 825,000 Est. Cost $52.35 Unrealized -27.8%
CDNA CAREDX INC 2.4%
Value $25.88M Shares 1,200,000 Est. Cost $24.20 Unrealized -5.2%
GLOBAL BLOOD THERAPEUTICS IN 2.2%
Value $23.85M Shares 300,000 Est. Cost $32.45 Unrealized
DNLI DENALI THERAPEUTICS INC 2.0%
Value $21.77M Shares 1,250,000 Est. Cost $18.64 Unrealized -10.7%
FULC FULCRUM THERAPEUTICS INC 1.9%
Value $20.62M Shares 1,239,285 Est. Cost $10.58 Unrealized -9.7%
ILMN ILLUMINA INC 1.8%
Value $19.9M Shares 60,000 Est. Cost $196.93 Unrealized +53.9%
GRITSTONE ONCOLOGY INC 1.8%
Value $19.38M Shares 2,160,000 Est. Cost $3358.13 Unrealized
ALEC ALECTOR INC 1.7%
Value $18.54M Shares 1,076,039 Est. Cost $18.52 Unrealized -8.2%
SAGE THERAPEUTICS INC 1.5%
Value $16.6M Shares 230,000 Est. Cost $89.71 Unrealized
GENMARK DIAGNOSTICS INC 1.5%
Value $16.19M Shares 3,365,000 Est. Cost $6.69 Unrealized
DECIPHERA PHARMACEUTICALS IN 1.5%
Value $15.87M Shares 255,000 Est. Cost $13347.64 Unrealized
VYGR VOYAGER THERAPEUTICS INC 1.4%
Value $15.28M Shares 1,095,075 Est. Cost $14.86 Unrealized
ADPT ADAPTIVE BIOTECHNOLOGIES COR 1.3%
Value $13.86M Shares 463,125 Est. Cost $44.30 Unrealized -35.2%
GILD GILEAD SCIENCES INC 1.2%
Value $13M Shares 200,000 Est. Cost Unrealized
SGMO SANGAMO THERAPEUTICS INC 1.1%
Value $12.18M Shares 1,455,000 Est. Cost $8.80 Unrealized +4.5%
ORCHARD THERAPEUTICS PLC 1.0%
Value $11.28M Shares 820,000 Est. Cost $4757.09 Unrealized
TWST TWIST BIOSCIENCE CORP 0.6%
Value $6.3M Shares 300,000 Est. Cost $26.45 Unrealized -11.5%
TURNING POINT THERAPEUTICS I 0.4%
Value $4.672M Shares 75,000 Est. Cost $40080.00 Unrealized
BRISTOL MYERS SQUIBB CO 0.4%
Value $4.515M Shares 1,500,000 Est. Cost $3.01 Unrealized
STOK STOKE THERAPEUTICS INC 0.3%
Value $3.682M Shares 130,000 Est. Cost $27.21 Unrealized -7.6%